Search Results 81-90 of 21194 for anti-TNF drugs

1. A Study to Evaluate both the Efficacy and Safety Profile of CP-690,550 in Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... anti-TNF-alpha therapy. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

2. A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with ...

3. Alzheimer's: Medicines help manage symptoms and slow decline - Mayo Clinic

   FDA-approved medicines for treating symptoms · Goals for treating symptoms · Cholinesterase inhibitors · Memantine · Medicine for agitation · Anti-amyloid treatment.

4. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

   18-80 years of age, inclusive · Moderately to severely active UC as determined by the Mayo Clinic Score assessment (MCS) · Naive to treatment with any anti-TNF ...

5. Hidradenitis Suppurativa Clinical Trials - Mayo Clinic Research

   ... Anti‑TNF Therapy. Amended Protocol to Include a Lutikizumab Open-Label Sub-study in Subjects Naïve to Biologic Therapy. A Study to Evaluate the Safety and ...

6. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Descriptions. Ophthalmic anti-inflammatory medicines are used in the eye to lessen problems that can occur during or after some kinds of eye surgery. Sometimes, ...

7. Infliximab-Qbtx (Intravenous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

8. A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis - Mayo Clinic

   A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to ...

9. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... A maximum of approximately 80% of subjects with any prior anti-TNF ...

10. Infliximab (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...